Efficient drug delivery and anticancer effect of micelles based on vitamin E succinate and chitosan derivatives
Xiaotong Chen,Junxiang Gu,Le Sun,Wenya Li,Lili Guo,Zhiyang Gu,Litong Wang,Yan Zhang,Wangwang Zhang,Baoqin Han,Jing Chang
DOI: https://doi.org/10.1016/j.bioactmat.2021.02.028
IF: 18.9
2021-10-01
Bioactive Materials
Abstract:A nano-micellar system (<em>O</em>-CMCTS-VES) constituted by carboxymethyl chitosan and vitamin E succinate was fabricated.The micelles hold high cytocompatibility, hemocompatibility, tissue compatibility, and drug load contents.Drug release experiments implied good pH sensitivity and sustained-release effect of <em>O</em>-CMCTS-VES.<em>O</em>-CMCTS-VES loading DOX showed efficient anti-tumor effect <em>in vitro</em> and <em>in vivo.</em>Nanocarriers have emerged as a promising cancer drug delivery strategy. Multi-drug resistance caused by overexpression of multiple-drug excretion transporters in tumor cells is the major obstacle to successful chemotherapy. Vitamin E derivatives have many essential functions for drug delivery applications, such as biological components that are hydrophobic, stable, water-soluble enhancing compounds, and anticancer activity. In addition, vitamin E derivatives are also effective mitocan which can overcome multi-drug resistance by binding to P glycoproteins. Here, we developed a carboxymethyl chitosan/vitamin E succinate nano-micellar system (<em>O</em>-CMCTS-VES). The synthesized polymers were characterized by Fourier Transform IR, and <sup>1</sup>H NMR spectra. The mean sizes of <em>O</em>-CMCTS-VES and DOX-loaded nanoparticles were around 177 nm and 208 nm. The drug loading contents were 6.1%, 13.0% and 10.6% with the weight ratio of DOX to <em>O</em>-CMCTS-VES corresponding 1:10, 2:10 and 3:10, and the corresponding EEs were 64.3%, 74.5% and 39.7%. Cytotoxicity test, hemolysis test and histocompatibility test showed that it had good biocompatibility <em>in vitro</em> and <em>in vivo</em>. Drug release experiments implied good pH sensitivity and sustained-release effect. The DOX/<em>O</em>-CMCTS-VES nanoparticles can be efficiently taken up by HepG2 cancer cells and the tumor inhibition rate is up to 62.57%. In the <em>in vivo</em> study by using H22 cells implanted Balb/C mice, DOX/<em>O</em>-CMCTS-VES reduced the tumor volume and weight efficiently with a TIR of 35.58%. The newly developed polymeric micelles could successfully be utilized as a nanocarrier system for hydrophobic chemotherapeutic agents for the treatment of solid tumors.Schematic diagram of the <em>O-</em>CMCTS-VESnanoparticles with EPReffect for anticancer therapy.<span class="display"><span><ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X2100089X-ga1_lrg.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download high-res image (309KB)</span></span></a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X2100089X-ga1.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download full-size image</span></span></a></li></ol></span></span>
engineering, biomedical,materials science, biomaterials